Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

The 2026 Pharma Marketing Pulse: Navigating the Intersection of Trends, Technology, and Trust

February 20, 2026

Discover the key findings from our 2026 Pharma Marketing Pulse and learn how to stay ahead of the trends in a rapidly shifting media landscape.

Expanding Patient Voices and Understanding Their Perspectives

WHITEPAPER DOWNLOAD: Patient Experience in Clinical Trials

August 28, 2018

Download the whitepaper, "Patient Experience in Clinical Trials," which analyzes differences in the perceptions of those who have participated in a clinical trial in the last five years to those participants prior to 2013, and how to dispel the myths that exist in the industry by looking through a true patient-centric lens.

The secret to sustainable growth: Hiring a mindset, not a skill set

August 28, 2018

Think for a moment how a car simply can’t run without both gasoline and oil. You can’t really argue which one is more important because that doesn’t matter: without either, the car won’t go. Everything in our business works like gas and oil in a car: because each individual understands that, no matter their role, what they do is crucial to our success.

People with COPD want more from their doctors: Here’s what they say

August 14, 2018

Debilitating. Frustrating. Devastating. When asked to describe their condition in one word, COPD patients’ choice of words reveals struggle, fear, misery, and helplessness in Health Union’s COPD In America 2018 survey.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

Healthcare Industry Thought Leadership

The 2026 Pharma Marketing Pulse: Navigating the Intersection of Trends, Technology, and Trust

WHITEPAPER DOWNLOAD: Patient Experience in Clinical Trials

The secret to sustainable growth: Hiring a mindset, not a skill set

People with COPD want more from their doctors: Here’s what they say

Differences in DMT treatment experiences among people with MS: Here’s what patients say

Heartbeats vs. Heatmaps: Why the Future of Pharma Media is Human

The “Buy Now” Era of Pharma: Navigating Pharma’s Direct-to-Patient Revolution

The Authority Gap: Why Trust is Pharma’s Only Real Currency in 2026

Debunking the 5 Biggest Myths About Community-Based Advertising

Contact